data_type: yeast_RBD_DMS

study_title: Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies

study_first_author: Greaney

study_year: 2021

study_url: https://www.biorxiv.org/content/10.1101/2020.12.31.425021v1

spike: Wuhan-Hu-1

experimental_system: yeast display

notes: "Data taken from Supplementary Table 3, which is also available here: https://raw.githubusercontent.com/jbloomlab/SARS-CoV-2-RBD_MAP_HAARVI_sera/main/results/supp_data/human_sera_raw_data.csv."

conditions:
  subject A (day 21): &default
    type: serum
    subtype: convalescent serum
    year: 2020
    notes: null
  subject A (day 120): *default
  subject A (day 45): *default
  subject B (day 26): *default
  subject B (day 113): *default
  subject C (day 32): *default
  subject C (day 104): *default
  subject D (day 33): *default
  subject D (day 76): *default
  subject E (day 28): *default
  subject E (day 104): *default
  subject F (day 48): *default
  subject F (day 115): *default
  subject G (day 18): *default
  subject G (day 94): *default
  subject H (day 61): *default
  subject H (day 152): *default
  subject I (day 26): *default
  subject I (day 102): *default
  subject J (day 15): *default
  subject J (day 121): *default
  subject K (day 29): *default
  subject K (day 103): *default
